Partners

The Society of Dermatology Physician Assistants offers their view on the role of the physician assistant in the dermatologic care of patients throughout the United States.

Personal protective equipment has caused an increase in iatrogenic dermatoses, such as contact dermatitis and acne, that need to be handled with care to protect and treat hyperpigmentation.

While several comorbidities have been associated with psoriasis, dermatologists should know the risks and complications of hepatic disease for this patient group.

While anyone can present with rosacea, this condition is often underdiagnosed among patients with darker phototypes. Dr Susan Taylor shares her clinical pearls for identifying rosacea in patients with skin of color.

As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.

Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.

New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.

Patients often describe seeking alternatives and adjuncts to care for the treatment of their atopic dermatitis. The literature has explored some of the potential in these options.

Phototherapy continues to be a mainstay of psoriasis treatment. Dr Gelfand highlights recommendations for phototherapy administration and patient discussions during the COVID-19 pandemic.

The time away from clinic due to the pandemic has left many with time to contemplate current affairs and their dermatology practice. Sarah Patton, MSHS, PA-C, reflects on how her life and career has changed over the course of 4 months.